FDA Inspection 623869 — Roche Molecular Systems, Inc.

Roche Molecular Systems, Inc. — FEI 2243471

The FDA completed an inspection of Roche Molecular Systems, Inc. on Oct 20, 2009 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 4 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 20, 2009
Fiscal Year
2010
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Branchburg, NJ (United States)

Citations

IDCFRDescription
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
369221 CFR 820.100(a)(4)CAPA verification/validation of corrective/preventive action
369621 CFR 820.100(b)Documentation
418921 CFR 820.198(a)General

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.